Eli Lilly lifts 2026 revenue guidance as Q1 marks dominant opening
Sales for Lilly blew past expectations in the quarter as demand for weight loss treatments showed no signs of abating.
Sales for Lilly blew past expectations in the quarter as demand for weight loss treatments showed no signs of abating.
Strong systems that enable trust and governance are key to enabling the growth of AI technologies in drug development.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential